CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Sanofi-Aventis U.S. LLC v. Eli Lilly and Company

1:14-cv-00113

Overview

Case Number 1:14-cv-00113
Filing Date 2014-01-30
Status Terminated
Termination Date 2015-09-28
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Movant

Thomas E. Wettermann NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 661-7394

The Nemours Building, 1007 North Orange Street, Suite 1200

David M. Frischkorn NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 661-7394

The Nemours Building, 1007 North Orange Street, Suite 1200

Defendant

Sanofi-Aventis U.S. LLC Operating Company

Represented By

10 Attorneys Listed

Anne Champion

Email: achampion@gibsondunn.com

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Lauren E. Maguire

Delaware Department of Justice

Tel: +1 (302) 577-8400

Delaware Department of Justice, 820 North French Street

R. Scott Roe

Email: sroe@gibsondunn.com

Tracey B. Davies

Email: tdavies@gibsondunn.com

Joseph Evall

Email: JEvall@gibsondunn.com

Samantha N. Hong

Email: snhong@gibsondunn.com

Jessica L. Greenbaum

Email: jgreenbaum@gibsondunn.com

Eli Lilly and Company Operating Company

Represented By

9 Attorneys Listed

Steven L. Park

Email: stevenpark@paulhastings.com

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Kevin P. Broughel

Email: kevinbroughel@paulhastings.com

Gerald J. Flattmann , Jr.

Email: gflattmann@cahill.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Young J. Park

Email: youngpark@paulhastings.com

Nicholas A. Tymoczko

Email: nicholastymoczko@paulhastings.com

David M. Conca

Email: davidconca@paulhastings.com

Bruce M. Wexler

Email: brucewexler@paulhastings.com

Plaintiff

Sanofi-Aventis Deutschland GmbH NPE (Individual / Inventor)

Represented By

4 Attorneys Listed

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Lauren E. Maguire

Delaware Department of Justice

Tel: +1 (302) 577-8400

Delaware Department of Justice, 820 North French Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 2 proceedings
🏛️
USPTO PTAB Trials 2 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): GB 🇺🇸 US
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 2 U.S. Courts: 2
USPTO PTAB Trial 2017-06-05
IPR2017-01528

Mylan Pharmaceuticals Inc., et al. v. Sanofi Aventis Deutschland GmbH et al.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-06-05
IPR2017-01526

Mylan Pharmaceuticals Inc., et al. v. Sanofi Aventis Deutschland GmbH et al.

U.S. Continuation Sibling (7476652)
Status: Final Written Decision
U.S. District Court 2016-09-16
1:16-cv-00812

Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp.

Asserted Patent
Status: DED
U.S. District Court 2014-07-07
1:14-cv-00884

Sanofi-Aventis U.S. LLC v. Eli Lilly and Company

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8556864
Drive mechanisms suitable for use in drug delivery devices
Filed: 2011-03-30
Issued: 2013-10-15
Expired (Term Ended)
Expires: 2024-12-29
US8603044
Pen-type injector
Filed: 2013-06-04
Issued: 2013-12-10
Active (6.5 yrs remaining)
Expires: 2033-06-04
US7476652
Acidic insulin preparations having improved stability
Filed: 2005-03-25
Issued: 2009-01-13
Expired (Term Ended)
Expires: 2023-07-23
US7713930
Acidic insulin preparations having improved stability
Filed: 2008-12-04
Issued: 2010-05-11
Active (2.0 yrs remaining)
Expires: 2028-12-04

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

18

Dispositive

5

Granted

0

Denied

1

Pending / Review

15

Motions by Category

Motion to Dismiss 5 Claim Construction / Markman Filing 11 Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Motion to Dismiss Denied
ORAL ORDER: As stated at the Rule 16 Conference, the MOTION to Dismiss (D.I. 12 ) is DENIED. Ordered by Judge Richard G. Andrews on 4/15/2014. (nms)
Entry #— • 2014-04-15
Motion to Dismiss Pending / Under Review
REPLY BRIEF re 12 MOTION to Dismiss Defendant's Patent Misuse and Invalidity Counterclaims filed by Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (M...
Entry #25 • 2014-04-14 Document →
Motion to Dismiss Pending / Under Review
[SEALED] ANSWERING BRIEF in Opposition re 12 MOTION to Dismiss Defendant's Patent Misuse and Invalidity Counterclaims filed by Eli Lilly and Company.Reply Brief...
Entry #17 • 2014-04-03 Document →
Motion to Dismiss Pending / Under Review
MOTION to Dismiss Defendant's Patent Misuse and Invalidity Counterclaims - filed by Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis U.S. LLC. (Attachments: # 1 ...
Entry #12 • 2014-03-17 Document →
Motion to Dismiss Pending / Under Review
OPENING BRIEF in Support re 12 MOTION to Dismiss Defendant's Patent Misuse and Invalidity Counterclaims filed by Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis...
Entry #13 • 2014-03-17 Document →
Claim Construction / Markman Filing Pending / Under Review
MEMORANDUM OPINION providing claim construction for the terms in dispute. Within five days the parties shall submit a proposed order consistent with this Memor...
Entry #192 • 2015-01-20 Document →

Docket Entries

(380 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Eli Lilly and Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1451198.) - filed by Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(dmp, ) (Entered: 01/31/2014)

Entry #1 • 2014-01-30
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 01/31/2014)

Entry #2 • 2014-01-30
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/20/2013. Date of Expiration of Patent: 03/03/2024.Thirty Month Stay Deadline: 6/20/2016. (dmp, ) (Entered: 01/31/2014)

Entry #3 • 2014-01-30
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,556,864 B2; 8,603,044 B2; 7,476,652 B2; 7,713,930 B2;. (dmp, ) (Entered: 01/31/2014)

Entry #4 • 2014-01-30
1

No Summons Issued. (dmp, )

Entry #5 • 2014-01-30
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc